Modified PDT protocols prove promising for AK treatment, maintaining high clearance rates while reducing cost, one expert says.
Following guidelines will help to ensure more consistent outcomes, expert says. Biopsy success rests less on the type of biopsy than the expertise of the physician. Read the recommendations.
A new study reveals that toxin-producing bacteria like staphylococcus may fuel CTCL; therefore, antibacterial treatment may slow disease progression. Findings could one day change how you treat patients.
Dr. Hensin Tsao, shares his insight on why skin cancer cases are increasing, how new immunotherapy treatments bring hope and why dermatologists should be on the look out for new challenges.
Melanoma patients with fewer than 50 nevi may develop more aggressive melanomas than those with greater than 50 nevi, underscoring the need for education and consideration for skin cancer screening in all patients based on their overall risk.
Concerns have been raised over an FDA Drug Safety Communication about spontaneously submitted adverse reactions in patients using this topical treatment for actinic keratosis as well as labeling changes that were implemented because of those reports. One expert offers perspective.
The medical landscape has changed dramatically for advanced melanoma since 2011, with both individual and combination therapy regimens gaining approval in even recent months. While modern genomics knowledge and knowledge of the immune system have brought about significant improvements in response and longer survival periods for some patients, there is still no cure.
Study finds women diagnosed with malignant melanoma during their pregnancy or within one year of giving birth were more than five times more likely to die than women who weren't pregnant. Routine skin examinations may need to be included as part of postpartum appointments.
While highly sensitive technology is important for detecting melanoma, methods with poor sensitivity can lead to unnecessary biopsies, treatments, cost, as well as morbidity. Several technologies are available to improve sensitivity and specificity, some of which are used as second-level tests.
New technologies for managing skin cancer were a topic of discussion at a scientific session at the American Society for Dermatologic Surgery’s 2015 annual meeting in Chicago in October. Seaver L. Soon, M.D., division of dermatology and dermatologic surgery at Scripps Clinic, La Jolla, Calif., was one of the moderators for the scientific discussion titled, “The Cutting Edge: New Technologies for Managing Skin Cancer.” Learn more